It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19)
- PMID: 34036334
- PMCID: PMC8194799
- DOI: 10.1093/cid/ciab480
It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19)
Erratum in
-
Correction to: It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019.Clin Infect Dis. 2023 Mar 4;76(5):965. doi: 10.1093/cid/ciac612. Clin Infect Dis. 2023. PMID: 36759184 Free PMC article. No abstract available.
Comment on
-
Impact of Tocilizumab on the Mortality of Patients With Coronavirus Disease 2019.Clin Infect Dis. 2021 Jun 15;72(12):e1156-e1157. doi: 10.1093/cid/ciaa1738. Clin Infect Dis. 2021. PMID: 33201178 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
